BNP/CALL/EDWARDS LIFESCIENCES/120/0.1/19.12.25

BNP/CALL/EDWARDS LIFESCIENCES/120/0.1/19.12.25 Share Price

DE000PC5C2Z4

Real-time Boerse Frankfurt Warrants 15:35:29 17/05/2024 BST
0.63 ^EUR	-7.35%

Current month	+30.77%
1 month	-16.05%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart EDWARDS LIFESCIENCES CORPORATION

Chart BNP/CALL/EDWARDS LIFESCIENCES/120/0.1/19.12.25

Latest news about EDWARDS LIFESCIENCES CORPORATION

Edwards Lifesciences : First Quarter 2024 Fact Sheet	05-15	PU
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	05-14	MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	05-13	MT
Edwards Lifesciences Faces EU Antitrust Complaint By Meril	05-13	MT

More news

Quotes 5-day view

Date	Price	Change
17/05/24	0.63	-7.35%
16/05/24	0.68	+4.62%
15/05/24	0.65	+22.64%
14/05/24	0.53	+1.92%
13/05/24	0.52	-5.45%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 03:35 pm

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	EDWARDS LIFESCIENCES CORPORATION
Issuer	BNP Paribas
WKN	PC5C2Z
ISIN	DE000PC5C2Z4
Date issued	21/02/2024
Strike	120 $
Maturity	19/12/2025 (581 Days)
Parity	10 : 1
Emission price	0.46 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.03 €
Lowest since issue	0.5 €
Spread	0.06 €
Spread %	8.22%

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).

Sector

More about the company